PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Although aging is a known risk factor for idiopathic pulmonary fibrosis (IPF), the pathogenic mechanisms that underlie the effects of advancing age remain largely unexplained. Some age-related neurodegenerative diseases have an etiology that is related to mitochondrial dysfunction. Here, we found that alveolar type II cells (AECIIs) in the lungs of IPF patients exhibit marked accumulation of dysmorphic and dysfunctional mitochondria. These mitochondrial abnormalities in AECIIs of IPF lungs were associated with upregulation of ER stress markers and were recapitulated in normal mice with advancing age in response to stimulation of ER stress. We found that impaired mitochondria in IPF and aging lungs were associated with low expression of PTEN-induced putative kinase 1 (PINK1). Knockdown of PINK1 expression in lung epithelial cells resulted in mitochondria depolarization and expression of profibrotic factors. Moreover, young PINK1-deficient mice developed similarly dysmorphic, dysfunctional mitochondria in the AECIIs and were vulnerable to apoptosis and development of lung fibrosis. Our data indicate that PINK1 deficiency results in swollen, dysfunctional mitochondria and defective mitophagy, and promotes fibrosis in the aging lung.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“| Pulmonary fibrosis | Whole‐body deletion of Pink1 | Accelerated development of bleomycin‐induced lung fibrosis linked to accumulation of dysfunctional mitochondria in AEC cells | Bueno et al (2015) |”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al (2015)
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“In accordance with this notion, genetic loss of Pink1 and Prkn accelerates the development of the fibrotic phenotype in bleomycin‐treated mice, linked to alveolar epithelial cell II (AECII) loss and accrued inflammation (Bueno et al, 2015; Kobayashi et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“Pink1 deficiency leads to mitochondrial damage and hence promotes lung fibrosis (56), whereas a decreased expression of mitochondrial fission proteins Drp1 and mitochondrial fission 1 protein induces cellular senescence via a Pink1-dependent manner (57).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [56]
Citations
Cites
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 1×
“Mitochondrial materials such as mtDNA that leak from damaged mitochondria have been reported to elucidate inflammatory responses (48, 49).”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765 · cited 1×
“The median age of diagnosis of IPF is approximately 66 years (4, 5).”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Whereas the familial disease has been related to mutations in surfactant proteins and telomerase, the cause of the majority of sporadic IPF cases and the mechanisms involved in aging-related IPF susceptibility are still unknown (6, 7).”
BackgroundIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201
The role of mitochondria in aging
Bratic, A., & Larsson, N.-G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64125 · Cited by 1,087 · cited 1×
“Abnormalities in mitochondria are often observed with aging, including enlargement, loss of cristae, destruction of inner membranes, swelling, and impaired respiration (12).”
BackgroundDagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., & Chu, C. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808515200 · Cited by 954
Self-citation
Research works printed but not linked: 2
- Crapo, 1978, Lab Invest., 39, 640
- Malhotra, 2011, Cold Spring Harb Perspect Biol., 3, a004424
Cited by
Items 301–400 of 624
Fang, Z., Liu, G., Zhu, M., Wang, S., Jiang, Q., Loor, J. J., Yu, H., Hao, X., Chen, M., Gao, W., et al. (2022) · Journal of Dairy Science · doi:10.3168/jds.2021-21774 · Cited by 27
The role of Sirtuin 1 and its activators in age-related lung disease
Sun, C., Bai, S., Liang, Y., Liu, D., Liao, J., Chen, Y., Zhao, X., Wu, B., Huang, D., Chen, M., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114573 · Cited by 37
Yoon, Y. M., Han, Y., Yun, C. W., Lee, J. H., Kim, R., & Lee, S. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102898 · Cited by 28
“In CKD patients, mitochondrial size is increased by disruption, mitochondrial fission/fusion dynamics, and limited autophagosome elimination [16].”
BackgroundSelf-citationMechanisms of Age-Dependent Loss of Dietary Restriction Protective Effects in Acute Kidney Injury
Andrianova, N. V., Jankauskas, S. S., Zorova, L. D., Pevzner, I. B., Popkov, V. A., Silachev, D. N., Plotnikov, E. Y., & Zorov, D. B. (2018) · Cells · doi:10.3390/cells7100178 · Cited by 24
“It was shown that decreased PINK1 synthesis led to the fragmentation of mitochondria, decrease of the mitochondrial membrane potential [58], the development of fibrosis [59], which indicates the importance of the PINK1 protein in the normal functioning of mitochondria.”
BackgroundDemystifying pulmonary fibrosis
Jenkins, G. R. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00365.2020 · Cited by 24
“Somewhat worryingly in the context of the global COVID pandemic, a number of studies have demonstrated that virus-induced lung injury leads to worse pulmonary fibrosis in aged mice (7, 40, 57), and understanding the relationship between SARS-CoV-2 infection and ARDS in elderly patients, or those with telomere gene mut…”
BackgroundGlutamine restores mitochondrial respiration in bleomycin-injured epithelial cells
Shaghaghi, H., Para, R., Tran, C., Roman, J., Ojeda-Lassalle, Y., Sun, J., Romero, F., & Summer, R. S. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.006 · Cited by 26
Cantanhede, I. G., Liu, H., Liu, H., Rodriguez, V. B., Shiwen, X., Ong, V. H., Denton, C. P., Ponticos, M., Xiong, G., de Lima-Filho, J. L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1004949 · Cited by 29
“In addition, alveolar type II cells in IPF patients were found to exhibit marked accumulation of dysfunctional mitochondria (13).”
BackgroundLiu, B., Han, Y., Ye, Y., Wei, X., Li, G., & Jiang, W. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171396 · Cited by 27
Moghaddam, S. J., Savai, R., Salehi‐Rad, R., Sengupta, S., Kammer, M. N., Massion, P. P., Beane, J., Ostrin, E. J., Priolo, C., Tennis, M. A., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202406-1168st · Cited by 31
“An accumulation of dysmorphic and dysfunctional mitochondria together with low expression of PINK1 (PTEN-induced putative kinase 1) have been described in AT2 cells of patients with IPF, who may typically experience hypoxia (119).”
BackgroundRegulation of lung progenitor plasticity and repair by fatty acid oxidation
Angeles-López, Q. D., Rodriguez-Lopez, J., Garcia, P. A., Calyeca, J., Álvarez, D., Bueno, M., Tu, L. N., Salazar-Terreros, M. J., Vanegas-Avendaño, N., Krull, J. E., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.165837 · Cited by 33
“Our previous work shows that dysfunctional mitochondria significantly accumulate in AT2 cells from old and IPF lungs (22, 23).”
Self-citationMCTR3 reduces LPS-induced acute lung injury in mice via the ALX/PINK1 signaling pathway
Zhuang, R., Yang, X., Cai, W., Xu, R., Lv, L., Sun, Y., Guo, Y., Ni, J., Zhao, G., & Lu, Z. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107142 · Cited by 23
Does Regular Physical Activity Mitigate the Age-Associated Decline in Pulmonary Function?
Burtscher, J., Millet, G. P., Gatterer, H., Vonbank, K., & Burtscher, M. (2022) · Sports Medicine · doi:10.1007/s40279-022-01652-9 · Cited by 25
“At the molecular level, impaired mitochondrial quality control, likely in part due to an age-dependent decline in autophagy, has been shown to promote the accumulation of swollen and dysfunctional mitochondria in aging type II alveolar epithelial cells [40].”
BackgroundChillappagari, S., Schwarz, J., Kesireddy, V., Knöll, J., Korfei, M., Höetzenecker, K., Schmitz, M. L., Behl, C., Bellusci, S., Günther, A., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.935 · Cited by 21
Nita, M., & Grzybowski, A. E. (2020) · EXCLI journal · doi:10.17179/excli2020-2915 · Cited by 25
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF
Hohmann, M. S., Habiel, D. M., Espíndola, M. S., Huang, G., Jones, I. C., Narayanan, R., Coelho, A. L., Oldham, J. M., Noth, I., Ma, S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.141061 · Cited by 23
“Adding to this complexity is the fact that lymphocytes (8, 9); myeloid (10–13), epithelial (14, 15), endothelial (16–18), and mesenchymal cells (19–23); as well as several signaling pathways propagated in these cells (9,”
BackgroundLipid Metabolism: A New Player in the Conundrum of Lung Fibrosis
Summer, R. S., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0098ed · Cited by 23
Self-citationBone, N. B., Becker, E., Husain, M., Jiang, S., Zmijewska, A. A., Park, D., Chacko, B. K., Darley-Usmar, V. M., Grégoire, M., Tadié, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90573-0 · Cited by 23
Tu, M., Wei, T., Jia, Y., Wang, Y., & Wu, J. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-886 · Cited by 29
“Additionally, ATII cells in IPF lungs exhibit significant cellular senescence features such as mitochondrial malformations and dysfunction (28).”
Candidate genes of idiopathic pulmonary fibrosis: current evidence and research
Wang, Y., & Zhou, W. (2016) · The Application of Clinical Genetics · doi:10.2147/tacg.s61999 · Cited by 30
Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung
Kuroda, A., Hegab, A. E., Gao, J., Yamashita, S., Hizawa, N., Sakamoto, T., Yamada, H., Suzuki, S. O., Ishii, M., Namkoong, H., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0554-5 · Cited by 21
“In contrast, pathological conditions like hypoxia or increased oxidative stress result in “reduced-density” of the mitochondrial matrix [37, 38].”
BackgroundMichaeloudes, C., Bhavsar, P. K., Mumby, S. E., Chung, K. F., & Adcock, I. M. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-153aw · Cited by 25
Causes of Pulmonary Fibrosis in the Elderly
Ramírez, C. L., Suárez-Valdivia, L., & Portal, J. A. R. (2018) · Medical Sciences · doi:10.3390/medsci6030058 · Cited by 32
“Other studies focusing on fibroblasts showed that TGF-β stimulation of lung fibroblasts decreased PINK1 levels and promoted insufficient mitophagy and myofibroblast differentiation.”
BackgroundRoque, W., Boni, A. J., Manzano, J. M. M., & Romero, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113878 · Cited by 25
“Mitochondrial dysfunction is considered a pathogenic trigger in the development of age-related diseases, including IPF [77].”
BackgroundTang, W., Guo, R., Hu, C., Yang, Y., Yang, D., Chen, X., & Liu, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112111 · Cited by 25
Impaired AMPK control of alveolar epithelial cell metabolism promotes pulmonary fibrosis
Rodríguez, L. R., Alysandratos, K., Katzen, J. B., Murthy, A., Barboza, W. R., Tomer, Y., Bui, S., Perez, R. A., Petcherski, A., Minakin, K., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.182578 · Cited by 28
“JCI Insight 2025;10(15):e182578 https://doi.org/10.1172/jci.insight.182578 administration improved mitochondrial biogenesis and bioenergetics, leading to amelioration of pulmonary fibrosis, an effect mediated through PGC1 α and PINK1 (40).”
InfluentialPark, W., Kim, S.-J., Cheresh, P., Yun, J., Lee, B., Kamp, D. W., & Kim, D. (2021) · Biomaterials Science · doi:10.1039/d1bm00419k · Cited by 21
Gu, X., Long, Q., Wei, W., Tong, J., Li, Z., Zhang, Z., & Jiao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.830554 · Cited by 21
Xu, Q., Liu, S., Gong, Q., Zhu, R., Liu, J., Wu, Q., & Zhou, X. (2022) · Cells · doi:10.3390/cells12010137 · Cited by 21
Cala-García, J., Medina-Rincón, G. J., Sierra-Salas, P. A., Rojano, J., & Romero, F. (2023) · Biology · doi:10.3390/biology12091237 · Cited by 28
“By knocking down PINK1 on mice ATII cells, the authors detected an increase in profibrotic factors as well as observing dysmorphic and dysfunctional mitochondria in the ATIIs that were more vulnerable to apoptosis and the development of lung fibrosis [39].”
Kumari, S., Singh, P., & Singh, R. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111272 · Cited by 22
Ascher, K. B., Elliot, S. J., Rubio, G. A., & Glassberg, M. K. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.07.001 · Cited by 22
Ulke, H. M., Mutze, K., Lehmann, M., Wagner, D. E., Heinzelmann, K., Günther, A., Eickelberg, O., & Königshoff, M. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0047oc · Cited by 23
Post‐translational regulation of PGC‐1α modulates fibrotic repair
Larson‐Casey, J. L., Gu, L., Davis, D., Cai, G., Ding, Q., He, C., & Carter, A. B. (2021) · The FASEB Journal · doi:10.1096/fj.202100339r · Cited by 24
ZKSCAN3 in severe bacterial lung infection and sepsis-induced immunosuppression
Ouyang, X., Becker, E., Bone, N. B., Johnson, M. S., Craver, J., Zong, W., Darley-Usmar, V. M., Zmijewski, J. W., & Zhang, J. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00660-z · Cited by 20
“Lung fibrosis is also known to be accompanied by a loss of autophagy/mitophagy that prevents extracellular matrix clearance by phagocytes and parenchymal cells 50,51 .”
Nakamura, Y., & Shimizu, Y. (2023) · Cells · doi:10.3390/cells12040548 · Cited by 22
“Mitochondrial injury is known to stimulate apoptosis and profibrotic cytokines, leading to pulmonary fibrosis [122,123].”
BackgroundHong, J., Zhang, C., Zhong, W., Yang, H., Xiong, J., Deng, P., Yang, N., Chen, H., Jin, L., Guan, C., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115937 · Cited by 22
Proteomic analyses on chicken breast meat with white striping myopathy
Kong, B. C., Owens, C. M., Bottje, W. G., Shakeri, M., Choi, J., Zhuang, H., & BOWKER, B. C. (2024) · Poultry Science · doi:10.1016/j.psj.2024.103682 · Cited by 21
RNA‐Seq analysis of potential lncRNAs and genes for the anti‐renal fibrotic effect of norcantharidin
Xiao, H., Liao, Y., Tang, C., Zheng, X. W., Luo, H., Li, J., Liu, H., Sun, L., Zeng, D., & Li, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28999 · Cited by 19
Kesireddy, V., Chillappagari, S., Ahuja, S., Knudsen, L., Henneke, I., Graumann, J., Meiners, S., Ochs, M., Ruppert, C., Korfei, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900854r · Cited by 23
“These data are fully supported by data from patients with IPF, where defective autophagy has been reported (15).”
BackgroundDexmedetomidine Attenuates Lung Injury in Toxic Shock Rats by Inhibiting Inflammation and Autophagy
Li, Z.-B., Li, G., & Qin, J. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.11.001 · Cited by 20
Kumari, S., Singh, P., Dash, D., & Singh, R. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101943 · Cited by 21
Endoplasmic reticulum stress in acute lung injury and pulmonary fibrosis
Sun, Z., He, W., Meng, H., Li, P., & Qu, J. (2024) · The FASEB Journal · doi:10.1096/fj.202401849rr · Cited by 24
“51,52 In elderly IPF patients, increased levels of p16 and p21 were observed in lung epithelial cells; while in fibroblasts, overexpression of PGC-1 α could inhibit ER stress, reduce collagen production, and thus alleviate PF. 53 Aging leads to a decrease in molecular chaperone generation, which is…”
Wang, Z., Feng, F., He, H., Wu, Q., Gu, C., Hrovat, J., Peng, W., Xu, Y., Han, D., Yang, P., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153599 · Cited by 22
Taguchi, K., Elias, B. C., Krystofiak, E., Qian, S., Sant, S., Yang, H., Fogo, A. B., & Brooks, C. R. (2021) · Kidney360 · doi:10.34067/kid.0001602021 · Cited by 21
Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis
Li, S., Zhang, H., Chang, J., Li, D., & Cao, P. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174613 · Cited by 30
Mercader, J., Martín-Medina, A., Truyols-Vives, J., Escarrer-Garau, G., Elowsson, L., Montes‐Worboys, A., Río, C., Muncunill, J., Velasco-Roca, J., Cederberg, A., et al. (2023) · Cells · doi:10.3390/cells12162084 · Cited by 20
“Indeed, the hallmarks of aging, such as telomere shortening [9], loss of proteostasis, cellular senescence [10,11], and mitochondrial dysfunction [12,13], have been described in AEC, lung fibroblasts, and immune cells, the presence of which drives IPF.”
BackgroundResultInfluentialPINK1 Inhibits Multimeric Aggregation and Signaling of MAVS and MAVS-Dependent Lung Pathology
Kim, S., Shin, H. J., Yoon, C. M., Lee, S. W., Sharma, L., Cruz, C. S. D., & Kang, M. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0490oc · Cited by 20
A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes
Qiu, L., Gong, G., Wu, W., Li, N., Li, Z., Chen, S., Li, P., Chen, T., Zhao, H., Hu, C., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4545 · Cited by 19
“The pathophysiological pathogenesis of IPF involves aberrant transcription and gene expression (9-14).”
BackgroundEpithelial damage and ageing: the perfect storm
Hewitt, R. J., Pearmain, L., Lyka, E., & Dickens, J. A. (2025) · Thorax · doi:10.1136/thorax-2024-222060 · Cited by 23
“52 Often thought of as ‘second hits’, environmental insults are usually inhaled and exacerbate aberrant behaviour of already vulnerable AT2 cells and ultimately lead to the development of IPF.”
Chung, K., Huang, Y., Chen, Y., Juan, Y., Hsu, C., Nakahira, K., Huang, Y., Lin, M., Wu, S., Shih, J., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12843 · Cited by 20
Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis
Han, S., & Chandel, N. S. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0550tr · Cited by 18
Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases
Wang, J. Y., & Young, L. R. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0557tr · Cited by 20
Novel mediators of idiopathic pulmonary fibrosis
Saito, S., Deskin, B., Rehan, M., Yadav, S., Matsunaga, Y., Lasky, J. A., & Thannickal, V. J. (2022) · Clinical Science · doi:10.1042/cs20210878 · Cited by 20
Ban, J., Liu, F., Zhang, Q., Chang, S., Zeng, X., & Chen, J. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.10.004 · Cited by 18
Zuo, W., Wang, L., Tian, R., Wang, L., Liu, Y., Qian, H., Yang, X., & Liu, Z. (2023) · Current Vascular Pharmacology · doi:10.2174/0115701611269801231211104905 · Cited by 19
Hernández‐González, F., Pietrocola, F., Cameli, P., Bargagli, E., Prieto‐González, S., Cruz, T., Mendoza, N., Rojas, M. M., Serrano, M., Agustí, A. G. N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147554 · Cited by 19
“Recent research indicates that NF-κ B and CEBPB (CCAAT/enhancer-binding protein-β ) are crucial in inducing SASP factors, particularly by initiating an autocrine feedback loop involving IL-6 and IL-8 [45].”
BackgroundSelf-citationBukowska, A., Schild, L., Bornfleth, P., Peter, D., Wiese-Rischke, C., Gardemann, A., Isermann, B., Walles, T., & Goette, A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172875 · Cited by 20
Wu, J., Li, Y., yang, Y., Chen, R., Wang, H., Xie, K., Lan, J., Guo, M., Zhang, Y., & Li, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157240 · Cited by 23
Huang, Z., Wang, S., Liu, Y., Fan, L., Zeng, Y., Han, H., Zhang, H., Yu, X., Zhang, Y., Huang, D., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139923 · Cited by 18
Omote, N., & Sauler, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.603047 · Cited by 17
Liu, M., Zhang, Y., Dong, L., & Guo, Z. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.11.012 · Cited by 17
Li, Y., Du, Z., Li, T., Ren, X., Yu, Y., Duan, J., & Sun, Z. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138745 · Cited by 18
Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis
Kim, S., Lee, J. Y., Yoon, C. M., Shin, H. J., Lee, S. W., Rosas, I. O., Herzog, E. L., Cruz, C. S. D., Kaminski, N., & Kang, M. (2020) · European Respiratory Journal · doi:10.1183/13993003.00652-2020 · Cited by 19
Self-citationLiu, S., Xi, Q., Li, X., & Liu, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1535601 · Cited by 40
Mitochondrial dysfunction in fibrotic diseases: Research progress and MSC-exos therapy
Zhang, X., Wang, Y., Guo, X., Xiao, Y., Wan, W., Zou, H., & Yang, X. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.104983 · Cited by 18
Hermansky-Pudlak syndrome-2 alters mitochondrial homeostasis in the alveolar epithelium of the lung
Cuevas-Mora, K., Roque, W., Shaghaghi, H., Gochuico, B. R., Rosas, I. O., Summer, R. S., & Romero, F. (2021) · Respiratory Research · doi:10.1186/s12931-021-01640-z · Cited by 16
Zhou, J., Song, Y., Wang, X., Li, X., Liu, C., Tian, C., Wang, C., Li, L., Yan, G., & Cui, H. (2023) · Pharmaceuticals · doi:10.3390/ph16101444 · Cited by 17
Hoang, N.-M., Liu, Y., Bates, P. D., Heaton, A. R., Lopez, A. F., Liu, P., Zhu, F., Chen, R., Kondapelli, A., Zhang, X., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101484 · Cited by 23
Wang, Q., Zhu, K., & Zhang, A. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.174502 · Cited by 19
Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics
Li, H., Dai, X., Zhou, J.-F., Wang, Y., Zhang, S., Guo, J., Shen, L., Yan, H., & Jiang, H. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31370 · Cited by 20
“Recent studies have shown that the change in mitochondrial quality control is a key determinant of PF, and mitochondrial dynamics, as a dominating component, plays an important role in the occurrence and development of PF (Bueno et al., 2015; Larson ‐ Casey et al., 2016, 2020; Roque et al., 2020).”
Vasarmidi, E., Sarantoulaki, S., Trachalaki, A., Margaritopoulos, G. A., Bibaki, E., Spandidos, D. A., Tzanakis, Ν., & Antoniou, K. M. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9356 · Cited by 17
“may be an induction of the autophagy process in alveolar epithelial cells (AECs) in IPF, but finally the autophagy flux is impaired (31).”
BackgroundMitophagy in fibrotic diseases: molecular mechanisms and therapeutic applications
Cui, X. T., Zhou, Z., Tu, H., Wu, J., Zhou, J. P., Yi, Q., Liu, O., & Dai, X. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1430230 · Cited by 21
Tissue regeneration: Unraveling strategies for resolving pathological fibrosis
Li, J., Wang, S., Yuan, J., Mao, X., Wang, X., Zhang, L., Dong, Q., Chen, Z., Wang, Y., & Tang, N. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.002 · Cited by 23
Jiang, H., Zheng, B., Hu, G., Kuang, L., Zhou, T., Li, S., Chen, X., Li, C., Zhang, D., Zhang, J., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.100971 · Cited by 15
Zhang, Y., Shu, M., Shan, S., Liu, H., Zhang, Y., Song, C., Xu, Q., Fan, Y., & Lu, C. (2025) · Advanced Science · doi:10.1002/advs.202409383 · Cited by 29
Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
NAIR, G. B., Matela, A., Kurbanov, D., & Raghu, G. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1177461 · Cited by 14
“reticular stress and age related degenerative changes [35,36].”
BackgroundToll-like receptors and autophagy in interstitial lung diseases
Margaritopoulos, G. A., Lasithiotaki, I., & Antoniou, K. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.032 · Cited by 17
Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury
Vittal, R., Fisher, A. J., Thompson, E. L., Cipolla, E., Gu, H., Mickler, E. A., Varre, A., Agarwal, M., Kim, K. K., Vasko, M. R., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0463oc · Cited by 15
Morciano, G., Pellielo, G., Agyapong, E. D., Pellegrino, C., Patergnani, S., Franceschini, D., Koutsikos, K., Rigon, L., Pinton, P., & Rimessi, A. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07783-1 · Cited by 20
“Similar to other respiratory diseases, defective mitophagy contributes to ongoing inflammation and lung injury [8, 154–156].”
Bueno, M., Calyeca, J., Khaliullin, T. O., Miller, M. P., Álvarez, D., Rosas, L., Brands, J., Baker, C., Nasser, A., Shulkowski, S., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.161487 · Cited by 16
“Cyb5r3 fl/fl and Cyb5r3 SPC–KO mice were inoculated intranasally with saline solution or 5 × 10 4 PFU of MHV68 as described previously (9) and monitored daily.”
InfluentialSelf-citationWei, Y., Gao, S., Li, C., Huang, X., Xie, B., Geng, J., Dai, H., & Wang, C. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.04.008 · Cited by 17
Qi, L. I. N., Yating, L. I. N., Xinyan, L. I. A. O., Ziyi, C. H. E. N., Mengmeng, D. E. N. G., & Zhong, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-78136-5 · Cited by 22
Feng, J., Huang, X., Peng, Y., Yang, W., Yang, X., Tang, R. N., Xu, Q., Gao, Y., He, Z., Xing, S., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06199-7 · Cited by 21
“Abnormal mitochondrial dynamics have been associated with PF, with evidence showing increased mitochondrial fragmentation and dysfunction in AECs from patients with idiopathic pulmonary fibrosis, suggesting a significant role of mitochondrial dynamics in PF pathogenesis [18–21].”
Sun, B., Xu, S., Yan, Y., Li, Y., Li, H., Zheng, G., Dong, T., & Bai, J. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666191210115614 · Cited by 15
The Airway in Idiopathic Pulmonary Fibrosis: Protecting the Lung or Promoting Disease?
Ryu, C., Homer, R., & Herzog, E. L. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201601-0055ed · Cited by 15
“The study by Mathai and colleagues (11) also informs the paradigm of IPF pathogenesis, supported by previous ultrastructural studies of IPF lungs and biomarker studies, that suggests the initial injury to the lung occurs in the alveolar epithelium (1, 2).”
ResultUnderstanding the molecular regulatory mechanisms of autophagy in lung disease pathogenesis
Lin, L., Lin, Y., Han, Z., Wang, K., Zhou, S., Wang, Z., Wang, S., & Chen, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460023 · Cited by 14
Ba, J., Zheng, C., Lai, Y., He, X., Pan, Y., Zhao, Y., Xie, H., Wu, B., Deng, X., & Wang, N. (2025) · Respiratory Research · doi:10.1186/s12931-025-03201-0 · Cited by 13
“Buemo et al. found that AEC IIs in IPF patients displayed obvious mitochondrial dysfunction, with reduced mitophagy triggering cellular senescence [64].”
Self-citationPachéco, Y., Valeyre, D., Jammal, T. E., Vallée, M., Chevalier, F. P., Lamartine, J., Sigaudo‐Roussel, D., Verrier, B., Israël‐Biet, D., Freymond, N., et al. (2021) · Cells · doi:10.3390/cells10081995 · Cited by 16
Bruno, S. R., & Anathy, V. (2021) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01950-1 · Cited by 14
Kizawa, R., Araya, J., & Fujita, Y. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00295-1 · Cited by 15
“For example, AT2 cells undergo apoptosis so that IPF progresses through DNA damage, telomere shortening, oxidative stress, and mitochondrial dysfunction [53–56].”
BackgroundVitamin E stabilizes iron and mitochondrial metabolism in pulmonary fibrosis
Chang, J., Wang, J., Luo, B., Li, W., Xiong, Z., Du, C., Wang, X., Wang, Y., Tian, J., Li, S., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1240829 · Cited by 12
Metabolism and bioenergetics in the pathophysiology of organ fibrosis
Miguel, V., Alcalde‐Estévez, E., Sirera, B., Rodríguez‐Pascual, F., & Lamas, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.001 · Cited by 13
Song, Z., Li, J., & Gong, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156416 · Cited by 12
Thyroid hormone modulates hyperoxic neonatal lung injury and mitochondrial function
Vamesu, B. M., Nicola, T., Li, R., Hazra, S., Matalon, S., Kaminski, N., Ambalavanan, N., & Kandasamy, J. (2023) · JCI Insight · doi:10.1172/jci.insight.160697 · Cited by 16
“tosis and risk for disorders such as pulmonary fibrosis, asthma, and bronchitis (4, 5).”
BackgroundFine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis
Roque, W., Summer, R. S., & Romero, F. (2018) · Connective Tissue Research · doi:10.1080/03008207.2018.1529174 · Cited by 13
“in the ER (also known as ER stress) and enhance susceptibility to developing bleomycin-induced pulmonary fibrosis (52).”
BackgroundManning, E. P., Losier, A., Emeagwali, N., Ryu, C., & Honiden, S. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1700rr · Cited by 13
Dai, T., Liang, Y., Li, X., Zhao, J., Li, G., Li, Q., Xu, L., & Zhao, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1608750 · Cited by 12
Vinette, V., Aubry, I., Insull, H., Uetani, N., Hardy, S., & Tremblay, M. L. (2021) · The FASEB Journal · doi:10.1096/fj.202100207r · Cited by 11
Circular RNAs and their roles in idiopathic pulmonary fibrosis
Surendran, A. M., Huang, C., & Liu, L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02716-2 · Cited by 14
“AEC2 of IPF patients has shown a high level of dysfunctional mitochondria [28, 29].”
BackgroundMesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy
Wang, N., Ma, F., Song, H., He, N., Zhang, H., Li, J., Liu, Q., & Xu, C. (2025) · Cell Transplantation · doi:10.1177/09636897241311019 · Cited by 13
“EV-miR-135a derived from HUCMSCs promotes rat fibroblast migration and skin wound healing by inhibiting LATS2 expression 36 .”
Metadata
- Authors
- Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., Duncan, S. R., Rojas, M., Shiva, S., Chu, C. T., & Mora, A. L.
- Affiliations
- University of Pittsburgh (US)
- Universidad Nacional Autónoma de México (MX)
- Corresponding author
- Mora, Ana L.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-12-22
- Volume
- 125
- Issue
- 2
- Pages
- 521-538
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319413
- OpenAlex
- W2054760729
- Cited by
- 627
- References
- 65
- Citations by year
- 2026: 50 · 2025: 63 · 2024: 74 · 2023: 63 · 2022: 49 · 2021: 68 · 2020: 59 · 2019: 57 · 2018: 49 · 2017: 42 · 2016: 33 · 2015: 18
- FWCI
- 24.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Hemophilia Center of Western Pennsylvania
- National Institutes of Health (DK072506, NS065789)
- National Institute on Aging (AG026389, R01AG026389)
- National Heart, Lung, and Blood Institute (R01HL086884, R01HL123766)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072506)
- National Institute of Neurological Disorders and Stroke (NS065789, R01NS065789, R56NS065789)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- PINK1, idiopathic pulmonary fibrosis, lung aging, mitochondrial dysfunction, alveolar type II cells, endoplasmic reticulum stress, mitophagy, mitochondrial depolarization, apoptosis, mitochondrial homeostasis
- MeSH terms
- PTEN-Induced Putative Kinase, Aging, Animals, Humans, Mice, Inbred BALB C, Mitochondria, Protein Kinases, Pulmonary Alveoli, Up-Regulation, Apoptosis, Mice, Knockout, Cell Line, Tumor, Mice, Idiopathic Pulmonary Fibrosis, Endoplasmic Reticulum Stress, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.